Results 81 to 90 of about 152,693 (210)

Informational Requirements of A Mobile-Based System to Manage the Treatment of Stimulant Abusers

پیاورد سلامت, 2019
Background and Aim: Stimulants are among the most dangerous substances because of their physical and psychological side effects. The process of treating stimulant abusers is so complicated that makes the treatment very difficult.
Marjan Ghazi Saeedi, Masoomeh Amin Esmaeili, Sharareh Rostam Niakan Kalhori, Marzyeh Sadat Askari   +3 more
doaj  

Stimulating science [PDF]

Nature Structural & Molecular Biology, 2009
openaire   +2 more sources

Treatment patterns and comparative clinical outcomes of ADHD medications in adolescents and young adults with comorbid major depressive disorder. [PDF]

J Affect Disord
Baweja R, Waschbusch DA, Petrovic-Dovat L, Baweja R, Singh B, Singh MK, Waxmonsky JG.   +6 more
europepmc   +1 more source

Novel psychoactive substances: the pharmacology of stimulants and hallucinogens

Expert Review of Clinical Pharmacology, 2016
F. Schifano, D. Papanti, L. Orsolini, J. Corkery   +3 more
semanticscholar   +1 more source

Non-Medical Use of Prescription Stimulants in Australia: Prevalence, Sociodemographic and Substance Use Correlates From the 2022-2023 National Drug Strategy Household Survey. [PDF]

Drug Alcohol Rev
Johnson B, Chan G, Connor J, Stjepanovic D, Leung J, Sun T.   +5 more
europepmc   +1 more source

Prescription stimulant consumption in the United States compared with 35 other countries. [PDF]

Health Aff Sch
Bachhuber MA, Jordan AE, Piper BJ.
europepmc   +1 more source

ADHD medication discontinuation and non-adherence: a Norwegian population-based register study. [PDF]

BMJ Ment Health
Garcia-Argibay M, Hofstad T, Bjelland I, Cortese S, Mykletun A.   +4 more
europepmc   +1 more source

Stimulant use and increased severity of opioid use disorder and mental illness in patients with co-occurring disorders. [PDF]

J Subst Use Addict Treat
Kalmin MM, Crowley C, Bilder A, McCullough CM, Weir R, Griffin BA, Komaromy M, Watkins KE.   +7 more
europepmc   +1 more source

Naloxone Administration in Relation to Fentanyl, Xylazine, CNS Depressants, and Stimulants Exposure After Suspected Opioid Overdose: A Pilot Study. [PDF]

Acad Emerg Med
Merchant RC, Chapman B, Martinez PM, Krotulski A, Walton S, Carmen Vargas-Torres, Broach J, Babu KM.   +7 more
europepmc   +1 more source

Identification of distinct stimulant use trajectories and patterns of overdose. [PDF]

Addict Behav Rep
Shaw LC, Li Y, Noguchi JE, Park CJ, Biello KB, Hadland SE, Sherman SG, Macmadu A, Marshall BDL.   +8 more
europepmc   +1 more source